LAWLOR AUGUSTINE
SEC insider (Form 3/4/5 filer). CIK 0001262327. Director at PRF Technologies Ltd. (PRFX) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Mar 28, 2025. Located in CAMBRIDGE, MA.
Companies LAWLOR AUGUSTINE has filed insider reports for
- PRF Technologies Ltd. (PRFX): Director
- LEAP THERAPEUTICS, INC. (LPTX): Officer, Chief Operating Officer
LAWLOR AUGUSTINE
CIK: 0001262327
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (25.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Mar 28, 2025LPTX
LEAP THERAPEUTICS, INC.
ExerciseDirect22.5K shares- - Mar 28, 2025LPTX
LEAP THERAPEUTICS, INC.
Tax PaymentDirect7.8K shares at avg. $0.32$2K - Nov 13, 2024LPTX
LEAP THERAPEUTICS, INC.
In-the-MoneyIndirect2.1K shares at avg. $2.82$6K - Oct 2, 2024LPTX
LEAP THERAPEUTICS, INC.
AwardDirectEmployee Stock Option (Right to Buy)
85K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 28, 2025 |  LPTX LEAP THERAPEUTICS, INC. | Exercise | 22,500 | - | - | Direct |
| Mar 28, 2025 | LPTX LEAP THERAPEUTICS, INC. | Tax Payment | 7,797 | $0.32 | $2,469 | Direct |
| Nov 13, 2024 | LPTX LEAP THERAPEUTICS, INC. | In-the-Money | 2,136 | $2.82 | $6,024 | Indirect |
| Oct 2, 2024 | LPTX LEAP THERAPEUTICS, INC. | Award Employee Stock Option (Right to Buy) | 85,000 | - | - | Direct |
1-4 of 4 transactions